Congratulations to Dr Sam Kant, Consultant Nephrologist & Transplant Physician, SVUH & @ucddublin on being named the next Editor-in-Chief of ASN Kidney News from Jan 2027
A super recognition of Sam’s leadership & contribution to kidney care, research & education internationally
Looking forward to the 3rd Annual ILF Study Day this weekend! All info in the flyer below. Don’t miss out on what promises to be a great event 💚
@IrelandLiver@IrishLiverNurse@med_indonews
Happy Birthday to the Reeves Day Surgery unit @TUH_Tallaght today…..five years on from the first patient treated by Ms Emily Boyle
Now over 19,500 major cases under the watchful eyes of the senior nursing team….no wonder they are smiling
Well done to you all
𝗟𝗼𝗿𝗻𝗮 𝗠𝗮𝗿𝘀𝗼𝗻 is the new Chair of EKITA - European Kidney Transplant Association
🔹 Expanding education & training
🔹 Supporting young professionals
🔹 Promoting equity, diversity & inclusion
📍 Meet her at the Living Donation Kidney Transplantation Specialty Symposium
🗓️ 7-9 November | 📍 Prague | 🚨 𝗥𝗘𝗗𝗨𝗖𝗘𝗗 𝗙𝗘𝗘𝗦 𝗧𝗢𝗗𝗔𝗬 𝗢𝗡𝗟𝗬 | 🔗 https://t.co/Ef9OfUVSoH
#ESOT_EKITA #KidneyTransplant #Leadership
Linda was on oxygen 24/7. Now she’s back at work with over 70% lung function - thanks to a #raredisease#clinicaltrial led by Prof Cormac McCarthy at SVUH @UCDClinRes
Listen to her powerful story on @RTERadio1 Claire Byrne Show 👇
🎧 https://t.co/Gr51SPdrZq
#SVUH#PatientStory
📢 Seeking a driven post doc immunologist for a novel surgical innovation project 🔬- investigating the role of sentinel skin flaps in acute solid organ rejection.
🔗 Apply via the UCD vacancy page: https://t.co/teoIRDxhgE
@wo_jules@hrbireland@UCDMedicine@Irishimmunology
𝐓𝐲𝐩𝐞 𝟏 𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 is a chronic autoimmune disease caused by the immune-mediated destruction of insulin-producing pancreatic beta cells. After beta cells are destroyed, lifelong insulin replacement is required. Physiological consequences of inadequate handling of glucose are microvascular and macrovascular dysfunction, affecting multiple tissues. Manifestations include retinopathy, neuropathy, nephropathy, coronary vascular disease, peripheral vascular disease, cerebrovascular disease, poor wound healing, and susceptibility to infections.
To learn more about this NEJM Illustrated Glossary term, read the editorial “Replacement of Beta Cells for Type 1 Diabetes” by Kevan C. Herold, MD, and Jordan S. Pober, MD, PhD, from @yale: https://t.co/I92J2tEVl6
Explore more terms: https://t.co/kobNxmaQrY
🚨 Liver transplantation in #iCCA: where are we heading?
🟢 Early iCCA: 5-yr survival up to 73%
🧬 #Biomarkers for better selection
⚕️ LT + adjuvant therapy & new donor strategies
📖 Read more:
https://t.co/h9hvp5ru1p
#LiverTransplant#Hepatology
Oxford Uni spinout @Organ_Ox has been acquired by Japan’s Terumo Corp for $1.5B – the largest-ever acquisition for an Oxford spinout. OrganOx’s life-saving organ preservation tech has powered 6,000+ transplants worldwide. Read more: https://t.co/kERVLBkLhC
Congrats to oncology trainee Mary O’Reilly presenting data from her PhD on early onset colorectal cancer at ESMO GI 2025 @myESMO@RayMcDermott1@graokane@svuh
🔥POLCAGB Ph 3 neoadjuvant chemo vs neoadjuvant chemorads + chemo in locally adv GBC
➡️ closed at interim due to poor accrual
124 pts randomised
➡️ORR 74% vs 36%
➡️mOS 22mths vs 10ths
Imp data - rads has a role!
Nb 20% her2 amp in GBC- needs explored
#ASCO25@ASCO@OncoAlert
We welcome applications for our senior HPB fellowship @RoyalSurrey. We are the highest volume robotic HPB service in the UK. Great access to a wide range of open/MIS liver/pancreas/biliary surgery
https://t.co/Q1kWa7kYzo
@Augishealth@EAHPBA@IHPBA@roux_group@GuildfordHpb
This is a study we need. This question comes up all the time for older frail patients and hard to give them survival data
My first study I tried to publish with @AmerZureikatMD as faculty was this. We had 16 patients and about that many journal rejections @AnnSurgOncol